Could the heparanase/TGF-β axis modulation be considered for the SGLT2 inhibitors cardioprotection in obesity? A hypothesis-generating report
Year: 2025
Type: article
Source: Acta Diabetologica
Authors: Angelo Di Vincenzo, Marika Crescenzi, Marnie Granzotto, Federico Capone, Fausto Cortese, Paola Fioretto, Roberto Vettor, Marco Rossato
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: AstraZeneca
Award: G7158877545
OpenAlex ID: W4415535810
